We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
Cap. Flow
+$3.25B
Cap. Flow %
5.45%
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.14B
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$96.9M
3
NVDA icon
NVIDIA
NVDA
+$86.8M
4
MSFT icon
Microsoft
MSFT
+$86.3M
5
KO icon
Coca-Cola
KO
+$75M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$90.4M
2
CRH icon
CRH
CRH
+$79.8M
3
MCO icon
Moody's
MCO
+$63.3M
4
PG icon
Procter & Gamble
PG
+$61.9M
5
TSM icon
TSMC
TSM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 30.72%
2 Financials 12.76%
3 Healthcare 12.55%
4 Communication Services 9.75%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSI icon
676
Rush Street Interactive
RSI
$3.46B
$501K ﹤0.01%
23,043
-3,516
-13% -$67.3K
PRDO icon
677
Perdoceo Education
PRDO
$1.91B
$500K ﹤0.01%
13,450
-3,390
-20% -$112K
WAL icon
678
Western Alliance Bancorporation
WAL
$8.79B
$494K ﹤0.01%
+6,975
New +$581K
ACLS icon
679
Axcelis
ACLS
$4.4B
$494K ﹤0.01%
5,308
-608
-10% -$53.8K
PLAB icon
680
Photronics
PLAB
$1.85B
$491K ﹤0.01%
12,149
-7,322
-38% -$265K
CARG icon
681
CarGurus
CARG
$3.16B
$484K ﹤0.01%
14,219
+685
+5% +$22.4K
LMAT icon
682
LeMaitre Vascular
LMAT
$2.3B
$484K ﹤0.01%
4,433
-1,260
-22% -$120K
YELP icon
683
Yelp
YELP
$1.42B
$481K ﹤0.01%
19,434
+3,170
+19% +$80.3K
FTI icon
684
TechnipFMC
FTI
$29.8B
$480K ﹤0.01%
6,944
-3,883
-36% -$233K
TBPH icon
685
Theravance Biopharma
TBPH
$873M
$479K ﹤0.01%
29,492
+2,682
+10% +$47.4K
AMSC icon
686
American Superconductor
AMSC
$1.67B
$478K ﹤0.01%
+14,134
New +$446K
NXT icon
687
Nextpower Inc
NXT
$16B
$477K ﹤0.01%
3,958
-1,613
-29% -$179K
NYT icon
688
New York Times
NYT
$12.1B
$477K ﹤0.01%
5,697
-1,710
-23% -$129K
PPL
689
PPL Corp
PPL
$26.6B
$476K ﹤0.01%
12,461
CRVL icon
690
CorVel
CRVL
$3.07B
$475K ﹤0.01%
8,700
+1,868
+27% +$108K
MEDP icon
691
Medpace
MEDP
$15.2B
$472K ﹤0.01%
983
+136
+16% +$69.6K
CTLP
692
DELISTED
Cantaloupe
CTLP
$472K ﹤0.01%
43,665
-2,168
-5% -$22.9K
FE icon
693
FirstEnergy
FE
$28B
$471K ﹤0.01%
9,294
CPRX
694
DELISTED
Catalyst Pharmaceutical
CPRX
$470K ﹤0.01%
18,963
-2,033
-10% -$48.4K
ESE icon
695
ESCO Technologies
ESE
$8.61B
$468K ﹤0.01%
1,662
+27
+2% +$6.81K
FDS icon
696
Factset
FDS
$8.78B
$467K ﹤0.01%
2,150
+743
+53% +$173K
POWL icon
697
Powell Industries
POWL
$8.9B
$466K ﹤0.01%
2,583
-2,157
-46% -$353K
LOPE icon
698
Grand Canyon Education
LOPE
$3.67B
$464K ﹤0.01%
2,729
-309
-10% -$51.8K
CNP icon
699
CenterPoint Energy
CNP
$27.9B
$464K ﹤0.01%
10,746
EBF icon
700
Ennis
EBF
$538M
$463K ﹤0.01%
21,631
-6,129
-22% -$124K

Similar funds

Aviva's Q1 2026 Portfolio in Review

As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.

  • Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
  • Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
  • Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
  • Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
  • Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
  • Aviva opened 50 new positions and closed 66 in Q1 2026.
  • Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.